MYC and Barrett esophagus: A combination analysis of the three factors: p16 loss, MYC gain, and DNA aneusomy, identified BE cases with a high risk of neoplastic progression, with an HR increased by 8.7-fold (95% CI 2.6–29.8), as compared to those with a low risk of progression [96].